Loading…

Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers

ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohor...

Full description

Saved in:
Bibliographic Details
Published in:Muscle & nerve 2025-02, Vol.71 (2), p.208-215
Main Authors: Berard, Nicolas, Verschueren, Annie, Fortanier, Etienne, Grapperon, Aude‐Marie, Kouton, Ludivine, Rebouh, Hadia, Gallard, Julien, Salort‐Campana, Emmanuelle, Attarian, Shahram, Delmont, Emilien
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93
container_end_page 215
container_issue 2
container_start_page 208
container_title Muscle & nerve
container_volume 71
creator Berard, Nicolas
Verschueren, Annie
Fortanier, Etienne
Grapperon, Aude‐Marie
Kouton, Ludivine
Rebouh, Hadia
Gallard, Julien
Salort‐Campana, Emmanuelle
Attarian, Shahram
Delmont, Emilien
description ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change. Methods We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations. Results Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91. Discussion Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.
doi_str_mv 10.1002/mus.28318
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11708451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3152517341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</originalsourceid><addsrcrecordid>eNp1kV1rFDEUhoModlu98A_IgDf2YtuczcckV1KW-gFdemEL3oVMJtlNmUnWJFOZf2_q1qKCVwfOeXh4Dy9CbwCfAcar83HKZytBQDxDC8CyXVImxXO0wEDFkhP57Qgd53yHMQbB25foiEjOBWd4ga4vB2tKivvdnH0c4tYbPTSbGHyJyYdtE11zkedxX-KoizfNTdIhl92cbPGh2UylbmNo1jolb1N-hV44PWT7-nGeoNuPlzfrz8ur609f1hdXS0NIDWXbzpJOE8OoEyBdv2Kt7ImhvQOKpZbgDAXTC2M0oX3XMSJb4QgwxlvuJDlBHw7e_dSNtjc2lKQHtU9-1GlWUXv19yX4ndrGewXQYkEZVMP7R0OK3yebixp9NnYYdLBxyooA5ZxTYLyi7_5B7-KUQv2vUmzFoCX0QXh6oEyKOSfrntIAVg89qdqT-tVTZd_-Gf-J_F1MBc4PwA8_2Pn_JrW5_XpQ_gSg8p8u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3152517341</pqid></control><display><type>article</type><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</creator><creatorcontrib>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</creatorcontrib><description>ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change. Methods We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations. Results Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91. Discussion Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</description><identifier>ISSN: 0148-639X</identifier><identifier>ISSN: 1097-4598</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/mus.28318</identifier><identifier>PMID: 39668650</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Action potential ; Action Potentials - physiology ; Adult ; Amyloid Neuropathies, Familial - diagnosis ; Amyloid Neuropathies, Familial - genetics ; Amyloid Neuropathies, Familial - physiopathology ; Assessments ; Asymptomatic ; asymptomatic carriers ; Autonomic nervous system ; Biomarkers ; Clinical ; Electrochemistry ; Electrodiagnosis - methods ; electrophysiological monitoring ; familial amyloid polyneuropathy ; Female ; Heart rate ; Heterozygote ; Humans ; Latency ; Male ; Median nerve ; Medical records ; Middle Aged ; Mutation ; Nerve conduction ; Neural Conduction - physiology ; Neuropathy ; Parameter sensitivity ; Prealbumin - genetics ; Retrospective Studies ; Sensory neurons ; Skin ; small fiber testing ; Standardization ; Sympathetic nervous system ; Transthyretin</subject><ispartof>Muscle &amp; nerve, 2025-02, Vol.71 (2), p.208-215</ispartof><rights>2024 The Author(s). published by Wiley Periodicals LLC.</rights><rights>2024 The Author(s). Muscle &amp; Nerve published by Wiley Periodicals LLC.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</cites><orcidid>0000-0002-5591-2774</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39668650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berard, Nicolas</creatorcontrib><creatorcontrib>Verschueren, Annie</creatorcontrib><creatorcontrib>Fortanier, Etienne</creatorcontrib><creatorcontrib>Grapperon, Aude‐Marie</creatorcontrib><creatorcontrib>Kouton, Ludivine</creatorcontrib><creatorcontrib>Rebouh, Hadia</creatorcontrib><creatorcontrib>Gallard, Julien</creatorcontrib><creatorcontrib>Salort‐Campana, Emmanuelle</creatorcontrib><creatorcontrib>Attarian, Shahram</creatorcontrib><creatorcontrib>Delmont, Emilien</creatorcontrib><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><title>Muscle &amp; nerve</title><addtitle>Muscle Nerve</addtitle><description>ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change. Methods We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations. Results Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91. Discussion Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</description><subject>Action potential</subject><subject>Action Potentials - physiology</subject><subject>Adult</subject><subject>Amyloid Neuropathies, Familial - diagnosis</subject><subject>Amyloid Neuropathies, Familial - genetics</subject><subject>Amyloid Neuropathies, Familial - physiopathology</subject><subject>Assessments</subject><subject>Asymptomatic</subject><subject>asymptomatic carriers</subject><subject>Autonomic nervous system</subject><subject>Biomarkers</subject><subject>Clinical</subject><subject>Electrochemistry</subject><subject>Electrodiagnosis - methods</subject><subject>electrophysiological monitoring</subject><subject>familial amyloid polyneuropathy</subject><subject>Female</subject><subject>Heart rate</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Latency</subject><subject>Male</subject><subject>Median nerve</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Nerve conduction</subject><subject>Neural Conduction - physiology</subject><subject>Neuropathy</subject><subject>Parameter sensitivity</subject><subject>Prealbumin - genetics</subject><subject>Retrospective Studies</subject><subject>Sensory neurons</subject><subject>Skin</subject><subject>small fiber testing</subject><subject>Standardization</subject><subject>Sympathetic nervous system</subject><subject>Transthyretin</subject><issn>0148-639X</issn><issn>1097-4598</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kV1rFDEUhoModlu98A_IgDf2YtuczcckV1KW-gFdemEL3oVMJtlNmUnWJFOZf2_q1qKCVwfOeXh4Dy9CbwCfAcar83HKZytBQDxDC8CyXVImxXO0wEDFkhP57Qgd53yHMQbB25foiEjOBWd4ga4vB2tKivvdnH0c4tYbPTSbGHyJyYdtE11zkedxX-KoizfNTdIhl92cbPGh2UylbmNo1jolb1N-hV44PWT7-nGeoNuPlzfrz8ur609f1hdXS0NIDWXbzpJOE8OoEyBdv2Kt7ImhvQOKpZbgDAXTC2M0oX3XMSJb4QgwxlvuJDlBHw7e_dSNtjc2lKQHtU9-1GlWUXv19yX4ndrGewXQYkEZVMP7R0OK3yebixp9NnYYdLBxyooA5ZxTYLyi7_5B7-KUQv2vUmzFoCX0QXh6oEyKOSfrntIAVg89qdqT-tVTZd_-Gf-J_F1MBc4PwA8_2Pn_JrW5_XpQ_gSg8p8u</recordid><startdate>202502</startdate><enddate>202502</enddate><creator>Berard, Nicolas</creator><creator>Verschueren, Annie</creator><creator>Fortanier, Etienne</creator><creator>Grapperon, Aude‐Marie</creator><creator>Kouton, Ludivine</creator><creator>Rebouh, Hadia</creator><creator>Gallard, Julien</creator><creator>Salort‐Campana, Emmanuelle</creator><creator>Attarian, Shahram</creator><creator>Delmont, Emilien</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5591-2774</orcidid></search><sort><creationdate>202502</creationdate><title>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</title><author>Berard, Nicolas ; Verschueren, Annie ; Fortanier, Etienne ; Grapperon, Aude‐Marie ; Kouton, Ludivine ; Rebouh, Hadia ; Gallard, Julien ; Salort‐Campana, Emmanuelle ; Attarian, Shahram ; Delmont, Emilien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Action potential</topic><topic>Action Potentials - physiology</topic><topic>Adult</topic><topic>Amyloid Neuropathies, Familial - diagnosis</topic><topic>Amyloid Neuropathies, Familial - genetics</topic><topic>Amyloid Neuropathies, Familial - physiopathology</topic><topic>Assessments</topic><topic>Asymptomatic</topic><topic>asymptomatic carriers</topic><topic>Autonomic nervous system</topic><topic>Biomarkers</topic><topic>Clinical</topic><topic>Electrochemistry</topic><topic>Electrodiagnosis - methods</topic><topic>electrophysiological monitoring</topic><topic>familial amyloid polyneuropathy</topic><topic>Female</topic><topic>Heart rate</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Latency</topic><topic>Male</topic><topic>Median nerve</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Nerve conduction</topic><topic>Neural Conduction - physiology</topic><topic>Neuropathy</topic><topic>Parameter sensitivity</topic><topic>Prealbumin - genetics</topic><topic>Retrospective Studies</topic><topic>Sensory neurons</topic><topic>Skin</topic><topic>small fiber testing</topic><topic>Standardization</topic><topic>Sympathetic nervous system</topic><topic>Transthyretin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berard, Nicolas</creatorcontrib><creatorcontrib>Verschueren, Annie</creatorcontrib><creatorcontrib>Fortanier, Etienne</creatorcontrib><creatorcontrib>Grapperon, Aude‐Marie</creatorcontrib><creatorcontrib>Kouton, Ludivine</creatorcontrib><creatorcontrib>Rebouh, Hadia</creatorcontrib><creatorcontrib>Gallard, Julien</creatorcontrib><creatorcontrib>Salort‐Campana, Emmanuelle</creatorcontrib><creatorcontrib>Attarian, Shahram</creatorcontrib><creatorcontrib>Delmont, Emilien</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Muscle &amp; nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berard, Nicolas</au><au>Verschueren, Annie</au><au>Fortanier, Etienne</au><au>Grapperon, Aude‐Marie</au><au>Kouton, Ludivine</au><au>Rebouh, Hadia</au><au>Gallard, Julien</au><au>Salort‐Campana, Emmanuelle</au><au>Attarian, Shahram</au><au>Delmont, Emilien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers</atitle><jtitle>Muscle &amp; nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2025-02</date><risdate>2025</risdate><volume>71</volume><issue>2</issue><spage>208</spage><epage>215</epage><pages>208-215</pages><issn>0148-639X</issn><issn>1097-4598</issn><eissn>1097-4598</eissn><abstract>ABSTRACT Introduction/Aims It is imperative to screen asymptomatic carriers of transthyretin (TTR) mutations to initiate treatment early. The protocol for repeated electrodiagnostic (EDX) assessments over time lacks standardization. Our aim was to report the electrophysiological evolution of a cohort of asymptomatic carriers and to determine which biomarkers were most sensitive to change. Methods We performed a retrospective review of medical records of asymptomatic carriers identified by screening families with amyloid neuropathy. Carriers who underwent two EDX assessments with a minimum 1‐year interval between studies were selected. EDX included analysis of median, ulnar, tibial, fibular and sural nerves, motor unit number index (MUNIX), electrochemical skin conductance, sympathetic skin response, and heart rate variability on deep breathing. Measurements were compared at first and second examinations. Results Twenty‐three carriers were included with a median age of 49 years (interquartile range 37–58). Median time between examinations was 3 years (2–4). Compound muscle and sensory nerve action potential (CMAP and SNAP) amplitudes, nerve conduction velocities, autonomic small fiber testing and MUNIX remained stable except for motor distal latency of the median nerve (+0.07 ms/year) and CMAP duration of the ulnar (+0.10 ms/year) and fibular (+0.12 ms/year) nerves. The CMAP duration of the ulnar nerve was the most sensitive biomarker to change when performed within 10 years preceding the age of the youngest case in the family, with a standardized response mean of 0.91. Discussion Nerve conduction parameters remain relatively stable in asymptomatic TTR carriers. Changes can only be detected using multimodal and extensive electrophysiological tests.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>39668650</pmid><doi>10.1002/mus.28318</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5591-2774</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0148-639X
ispartof Muscle & nerve, 2025-02, Vol.71 (2), p.208-215
issn 0148-639X
1097-4598
1097-4598
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11708451
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Action potential
Action Potentials - physiology
Adult
Amyloid Neuropathies, Familial - diagnosis
Amyloid Neuropathies, Familial - genetics
Amyloid Neuropathies, Familial - physiopathology
Assessments
Asymptomatic
asymptomatic carriers
Autonomic nervous system
Biomarkers
Clinical
Electrochemistry
Electrodiagnosis - methods
electrophysiological monitoring
familial amyloid polyneuropathy
Female
Heart rate
Heterozygote
Humans
Latency
Male
Median nerve
Medical records
Middle Aged
Mutation
Nerve conduction
Neural Conduction - physiology
Neuropathy
Parameter sensitivity
Prealbumin - genetics
Retrospective Studies
Sensory neurons
Skin
small fiber testing
Standardization
Sympathetic nervous system
Transthyretin
title Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrophysiological%20Monitoring%20of%20Asymptomatic%20Transthyretin%20Mutation%20Carriers&rft.jtitle=Muscle%20&%20nerve&rft.au=Berard,%20Nicolas&rft.date=2025-02&rft.volume=71&rft.issue=2&rft.spage=208&rft.epage=215&rft.pages=208-215&rft.issn=0148-639X&rft.eissn=1097-4598&rft_id=info:doi/10.1002/mus.28318&rft_dat=%3Cproquest_pubme%3E3152517341%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3348-e7be3ba3c54f819fd2579d3c4df1409a91fc41cd8cca34dbb53978f3155676f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3152517341&rft_id=info:pmid/39668650&rfr_iscdi=true